| test | Turkey | Austria | |
| Immunotherapy with Keytruda (Pembolizumab) | - | from $3,300 | from $15,000 |
Day 1
Day 2
Day 3
Day 4-5
Day 6
Day 7
Weeks 2-4
Please note that each patient"s experience may vary, and you should always follow the advice of your healthcare provider.
Dr. Bulent Karagoz is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in immunotherapy and targeted therapies for sarcoma, lymphoma, and lung cancer. Dr. Karagoz provides treatment at a facility affiliated with the prestigious Johns Hopkins Hospital.
Dr. Eda Tanrikulu is a clinical oncologist at Anadolu Medical Center in Istanbul. She ranked 3rd nationally in Turkey's minor specialty medical exam. Dr. Tanrikulu specializes in chemotherapy and individualized cancer treatments. She works at a facility affiliated with the Johns Hopkins Hospital.
Dr. Solak specializes in treating various cancers, including lung and gastrointestinal cancers, with extensive training at Hacettepe University Cancer Institute.
Leading researcher in immunotherapy trials – Dr. Raphael specializes in Keytruda (Pembrolizumab) at Sourasky Medical Center.
Keytruda, a form of immune-based therapy, leverages the body's immune system to target and destroy cancer cells using monoclonal antibodies.